Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Guo

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Advances in Therapy|April 24, 2023
Cost-Effectiveness Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) Versus Standard of Care for the Prevention of Recurrent Clostridioides difficile Infection in the USAThomas Lodise, Amy Guo, Min Yang, et al.
Advances in Therapy|April 24, 2023
Budget Impact Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) for Preventing Recurrent Clostridioides difficile Infection in the USThomas Lodise, Amy Guo, Min Yang, et al.
Current Medical Research and Opinion|November 13, 2009
Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patientsEric Q Wu, Scott Johnson, Nicolas Beaulieu, et al.
Cancer Medicine|January 24, 2013
Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancerReina Haque, Syed A Ahmed, Alice Fisher, et al.
AJR. American Journal of Roentgenology|February 22, 2008
Clinical and economic impact of falsely decreased calcium values caused by gadoversetamide interferenceManish J Gandhi, Vamsidhar R Narra, Jeffrey J Brown, et al.
Journal of Oncology Practice|August 15, 2013
Study of imatinib treatment patterns and outcomes among US veteran patients with Philadelphia chromosome-positive chronic myeloid leukemiaNancy Vander Velde, Lei Chen, Amy Guo, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 25, 2011
Comparison of skeletal complications and treatment patterns associated with early vs. delayed zoledronic acid therapy in multiple myelomaEric Q Wu, Arielle G Bensimon, Maryna Marynchenko, et al.
Clinical Genitourinary Cancer|June 12, 2012
Second-line treatment outcomes after first-line sunitinib therapy in metastatic renal cell carcinomaChi-Chang Chen, Gregory P Hess, Zhimei Liu, et al.
Biochemistry|June 14, 2008
Disulfide connectivity of human immunoglobulin G2 structural isoformsTheresa Martinez, Amy Guo, Martin J Allen, et al.
Urologic Oncology|March 29, 2023
The effect of treatment on work productivity in patients with bladder cancerLauren Ahlschlager, Sean McCabe, Allison M Deal, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Advances in Therapy|April 24, 2023
Cost-Effectiveness Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) Versus Standard of Care for the Prevention of Recurrent Clostridioides difficile Infection in the USAThomas Lodise, Amy Guo, Min Yang, et al.
Advances in Therapy|April 24, 2023
Budget Impact Analysis of REBYOTA™ (Fecal Microbiota, Live-jslm [FMBL]) for Preventing Recurrent Clostridioides difficile Infection in the USThomas Lodise, Amy Guo, Min Yang, et al.
Current Medical Research and Opinion|November 13, 2009
Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patientsEric Q Wu, Scott Johnson, Nicolas Beaulieu, et al.
Cancer Medicine|January 24, 2013
Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancerReina Haque, Syed A Ahmed, Alice Fisher, et al.
AJR. American Journal of Roentgenology|February 22, 2008
Clinical and economic impact of falsely decreased calcium values caused by gadoversetamide interferenceManish J Gandhi, Vamsidhar R Narra, Jeffrey J Brown, et al.
Journal of Oncology Practice|August 15, 2013
Study of imatinib treatment patterns and outcomes among US veteran patients with Philadelphia chromosome-positive chronic myeloid leukemiaNancy Vander Velde, Lei Chen, Amy Guo, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 25, 2011
Comparison of skeletal complications and treatment patterns associated with early vs. delayed zoledronic acid therapy in multiple myelomaEric Q Wu, Arielle G Bensimon, Maryna Marynchenko, et al.
Clinical Genitourinary Cancer|June 12, 2012
Second-line treatment outcomes after first-line sunitinib therapy in metastatic renal cell carcinomaChi-Chang Chen, Gregory P Hess, Zhimei Liu, et al.
Biochemistry|June 14, 2008
Disulfide connectivity of human immunoglobulin G2 structural isoformsTheresa Martinez, Amy Guo, Martin J Allen, et al.
Urologic Oncology|March 29, 2023
The effect of treatment on work productivity in patients with bladder cancerLauren Ahlschlager, Sean McCabe, Allison M Deal, et al.
Pageof 7